Mail

UK markets closed

FTSE 100
8,213.49
+41.34(+0.51%)
FTSE 250
20,164.54
+112.21(+0.56%)
AIM
771.53
+3.42(+0.45%)
GBP/EUR
1.1649
-0.0034(-0.29%)
GBP/USD
1.2547
+0.0014(+0.11%)
Bitcoin GBP
49,402.22
+2,261.24(+4.80%)

Best savings accounts that offer above inflation rates

Where to find a top-rated deal that works for you

Sinopharm Group Co. Ltd. (SHTDF)

Other OTC - Other OTC Delayed price. Currency in USD

Add to watchlist

2.6400

0.0000

(0.00%)

As of 10:40AM EDT. Market open.

Currency in USD

Valuation measures⁴

Market cap (intra-day)	7.75B
Enterprise value	9.12B
Trailing P/E	6.59
Forward P/E	8.46
PEG ratio (5-yr expected)	10.16
Price/sales (ttm)	0.10
Price/book (mrq)	0.80
Enterprise value/revenue	0.02
Enterprise value/EBITDA	0.34

Trading information

Stock price history

Beta (5Y monthly)	0.83
52-week change ³	-23.92%
S&P500 52-week change ³	22.43%
52-week high ³	3.4900
52-week low ³	2.3000
50-day moving average ³	2.7038
200-day moving average ³	2.6850

Share statistics

Avg vol (3-month) ³	367
Avg vol (10-day) ³	310
Shares outstanding ⁵	1.34B
Implied shares outstanding ⁶	3.3B
Float ⁸	1.34B
% held by insiders ¹	0.01%
% held by institutions ¹	61.67%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	0.12
Forward annual dividend yield ⁴	4.56%
Trailing annual dividend rate ³	0.87
Trailing annual dividend yield ³	32.95%
5-year average dividend yield ⁴	3.85
Payout ratio ⁴	28.75%
Dividend date ³	31 Aug 2017
Ex-dividend date ⁴	17 Jun 2024
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Mar 2024

Profitability

Profit margin	1.48%
Operating margin (ttm)	2.30%

Management effectiveness

Return on assets (ttm)	3.33%
Return on equity (ttm)	12.37%

Income statement

Revenue (ttm)	598.32B
Revenue per share (ttm)	191.73
Quarterly revenue growth (yoy)	1.20%
Gross profit (ttm)	N/A
EBITDA	23.79B
Net income avi to common (ttm)	8.88B
Diluted EPS (ttm)	0.4000
Quarterly earnings growth (yoy)	-10.70%

Balance sheet

Total cash (mrq)	48.91B
Total cash per share (mrq)	15.67
Total debt (mrq)	81.02B
Total debt/equity (mrq)	65.95%
Current ratio (mrq)	1.36
Book value per share (mrq)	24.40

Cash flow statement

Operating cash flow (ttm)	10.39B
Levered free cash flow (ttm)	-724.77M